Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Current Assets (2023 - 2025)

Historic Current Assets for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $129.5 million.

  • Artiva Biotherapeutics' Current Assets fell 1397.47% to $129.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.5 million, marking a year-over-year decrease of 1397.47%. This contributed to the annual value of $188.6 million for FY2024, which is 13631.75% up from last year.
  • Artiva Biotherapeutics' Current Assets amounted to $129.5 million in Q3 2025, which was down 1397.47% from $149.1 million recorded in Q2 2025.
  • In the past 5 years, Artiva Biotherapeutics' Current Assets registered a high of $188.6 million during Q4 2024, and its lowest value of $49.7 million during Q2 2024.
  • For the 3-year period, Artiva Biotherapeutics' Current Assets averaged around $131.1 million, with its median value being $149.1 million (2025).
  • Within the past 5 years, the most significant YoY rise in Artiva Biotherapeutics' Current Assets was 19963.62% (2025), while the steepest drop was 1397.47% (2025).
  • Quarter analysis of 3 years shows Artiva Biotherapeutics' Current Assets stood at $79.8 million in 2023, then surged by 136.32% to $188.6 million in 2024, then plummeted by 31.33% to $129.5 million in 2025.
  • Its Current Assets was $129.5 million in Q3 2025, compared to $149.1 million in Q2 2025 and $170.0 million in Q1 2025.